Malaysia Stands Firm on Worldwide Hepatitis B Birth Dose Despite US Policy Shift

malaysia will continue its longstanding practice of administering the hepatitis B vaccine within 24 hours of birth, reaffirming its commitment to newborn health despite a recent change in US policy. The decision underscores Malaysia’s reliance on global health recommendations and a decades-long track record of success with its current immunization program.

The Ministry of Health announced its position on December 26, 2025, following a vote by the US Advisory Committee on Immunisation Practices (ACIP) earlier this month to discontinue its universal suggestion for the hepatitis B birth dose.The revised recommendation, adopted by the US Centre for Disease Control and Prevention on December 16, now favors individualized decision-making for infants born to mothers who test negative for the virus.

Did you know? – Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease. The virus is most commonly spread through contact with infected blood.

A Commitment Rooted in Scientific Evidence

According to a ministry statement, Malaysia’s policy is firmly grounded in scientific evidence, local and global epidemiological data, and expert opinion. “The management of the hepatitis B vaccine birth dose within 24 hours of birth is crucial to prevent transmission of the hepatitis B virus from mother to child,” a senior official stated.

The Ministry emphasized the severe risks associated with early-life hepatitis B infection, noting that it carries a “high risk of becoming chronic, which could led to liver cirrhosis and liver cancer in adulthood.” This preventative measure, in place as 1989, has demonstrably reduced infection rates among children and contributed to long-term population health protection.

Diverging Paths: US and Malaysia

The US decision represents a significant shift from a long-standing universal approach. The ACIP now recommends that infants who do not receive the birth dose begin vaccination at a later stage. This change reflects a move towards a more targeted approach based on maternal hepatitis B status.

However, Malaysia remains steadfast in its belief that universal vaccination offers the most robust protection. “National immunisation policies are steadfast based on scientific evidence, local and global epidemiological data and expert opinion,” the ministry explained. “Any policy changes would only be considered if supported by strong evidence and international consensus.”

Pro tip – Ensure you discuss any concerns about vaccinations with your healthcare provider. they can provide personalized advice based on your and your baby’s health needs.

WHO Alignment and Parental Guidance

Malaysia’s continued adherence to the birth dose aligns with recommendations from the world Health Organisation (WHO). The Ministry of Health urged parents and caregivers to ensure their infants receive the vaccine according to the prescribed schedule.

This commitment to preventative healthcare highlights Malaysia’s proactive approach to public health and its dedication to safeguarding the well-being of its youngest citizens. The Ministry’s decision underscores the importance of evidence-based policymaking and the value of long-term investment in immunization programs.

Why: The Ministry of Health in malaysia decided to maintain its universal hepatitis B birth dose policy despite a change in US policy. This decision was made to prevent mother-to-child transmission of the virus and protect against long-term health risks.
Who: the key players are the Malaysian Ministry of Health, the US Advisory committee on Immunisation Practices (ACIP), the US Centre for Disease Control and Prevention (CDC), the World Health Organisation (WHO), parents, and caregivers.
What: The ACIP voted to discontinue its universal recommendation for the hepatitis B birth dose, opting for a targeted approach based on maternal hepatitis B status. malaysia, however, will continue to administer the vaccine to all newborns within 24 hours of birth.
How did it end?: The article concludes with Malaysia reaffirming its commitment to the current policy, aligning with WHO recommendations, and emphasizing the importance of preventative healthcare and evidence-based decision-making. The situation ended with a clear divergence in policy between the US and Malaysia, with Malaysia prioritizing universal vaccination for robust protection.